237 related articles for article (PubMed ID: 6418388)
1. Antibodies to plasminogen activator inhibit human tumor metastasis.
Ossowski L; Reich E
Cell; 1983 Dec; 35(3 Pt 2):611-9. PubMed ID: 6418388
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo.
Ossowski L
Cell; 1988 Feb; 52(3):321-8. PubMed ID: 3125981
[TBL] [Abstract][Full Text] [Related]
3. Early spontaneous metastasis in the human epidermoid carcinoma HEp3/chick embryo model: contribution of incidental colonization.
Gordon JR; Quigley JP
Int J Cancer; 1986 Sep; 38(3):437-44. PubMed ID: 3744594
[TBL] [Abstract][Full Text] [Related]
4. Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture.
Astedt B; Holmberg L
Nature; 1976 Jun; 261(5561):595-7. PubMed ID: 819839
[No Abstract] [Full Text] [Related]
5. Increased plasminogen activator inhibition levels in malignancy.
de Jong E; Knot EA; Piket D; Iburg AH; Rijken DC; Veenhof KH; Dooijewaard G; ten Cate JW
Thromb Haemost; 1987 Apr; 57(2):140-3. PubMed ID: 3110994
[TBL] [Abstract][Full Text] [Related]
6. Experimental model for quantitative study of metastasis.
Ossowski L; Reich E
Cancer Res; 1980 Jul; 40(7):2300-9. PubMed ID: 7190062
[TBL] [Abstract][Full Text] [Related]
7. Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.
Kirchheimer JC; Wojta J; Christ G; Binder BR
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5424-8. PubMed ID: 2501786
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse.
Ossowski L; Russo-Payne H; Wilson EL
Cancer Res; 1991 Jan; 51(1):274-81. PubMed ID: 1988089
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
[TBL] [Abstract][Full Text] [Related]
10. Amiloride selectively inhibits the urokinase-type plasminogen activator.
Vassalli JD; Belin D
FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
12. The concentration of u-PA and PAI-1 antigen in tissue extracts of nasopharyngeal carcinoma.
Sunagawa M; Huang GW; Nakamura M; Kosugi T
Eur Arch Otorhinolaryngol; 1997; 254(6):277-80. PubMed ID: 9248735
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
Sudol M; Reich E
Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
15. Rat testicular peritubular cells in culture secrete an inhibitor of plasminogen activator activity.
Hettle JA; Balekjian E; Tung PS; Fritz IB
Biol Reprod; 1988 Mar; 38(2):359-71. PubMed ID: 2833945
[TBL] [Abstract][Full Text] [Related]
16. Growth of a human carcinoma (HEp3) in nude mice: rapid and efficient metastasis.
Ossowski L; Russo H; Gartner M; Wilson EL
J Cell Physiol; 1987 Nov; 133(2):288-96. PubMed ID: 3119604
[TBL] [Abstract][Full Text] [Related]
17. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator secreted by cultured human melanocytes.
Hashimoto K; Horikoshi T; Nishioka K; Yoshikawa K; Carter DM
Br J Dermatol; 1986 Aug; 115(2):205-9. PubMed ID: 3091061
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on human activators of plasminogen.
Mackie M; Booth NA; Bennett B
Br J Haematol; 1981 Jan; 47(1):77-90. PubMed ID: 6449216
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of the inhibition by plasminogen activator inhibitor 2 of urokinase isolated from human urine and recombinant microorganisms. Further evidence for correct tertiary structure of recombinant urokinase.
Cramer J; Steffens G; Günzler WA; Hess V; Flohé L
Arzneimittelforschung; 1988 Aug; 38(8):1196-8. PubMed ID: 3143371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
